Structure Therapeutics, Inc. (GPCR)
51.78
-1.70
(-3.18%)
USD |
NASDAQ |
Apr 06, 16:00
51.75
-0.03
(-0.06%)
After-Hours: 19:23
Structure Therapeutics SG&A Expense (TTM) : 61.72M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| Viking Therapeutics, Inc. | 48.39M |
| Revolution Medicines, Inc. | 195.04M |
| Novo Nordisk A/S | 10.66B |
| Kymera Therapeutics, Inc. | 68.19M |